Empagliflozin 25 MG Oral Tablet

DRUG2 trials

Sponsors

The University of Texas Health Science Center at San Antonio, University of Minnesota

Conditions

DiabetesHeart Failure With Reduced Ejection FractionPartial Islet FunctionTPIATType2diabetes

Early Phase 1

Ketones, SGLT2, HFrEF

RecruitingNCT06229678

The University of Texas Health Science Center at San AntonioHeart Failure With Reduced Ejection Fraction, Type2diabetes

Start: 2024-01-25End: 2027-03-01Target: 71Updated: 2026-02-05

Phase 4

SGLT2i Therapy in Islet Transplantation (SIT)

RecruitingNCT07228195

University of MinnesotaDiabetes, Partial Islet Function, TPIAT

Start: 2026-07-21End: 2028-12-01Target: 40Updated: 2026-07-22